Insider Buying: Viewray Inc (NASDAQ:VRAY) CEO Buys $500,100.60 in Stock

Viewray Inc (NASDAQ:VRAY) CEO Scott William Drake bought 131,260 shares of the company’s stock in a transaction that occurred on Tuesday, August 13th. The stock was acquired at an average cost of $3.81 per share, for a total transaction of $500,100.60. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link.

Shares of NASDAQ:VRAY opened at $3.93 on Friday. Viewray Inc has a fifty-two week low of $2.76 and a fifty-two week high of $10.73. The company has a quick ratio of 3.21, a current ratio of 4.28 and a debt-to-equity ratio of 0.47. The company has a market cap of $387.03 million, a PE ratio of -4.01 and a beta of 0.79. The firm has a 50-day simple moving average of $8.08 and a 200 day simple moving average of $8.07.

Viewray (NASDAQ:VRAY) last posted its earnings results on Thursday, August 8th. The company reported ($0.32) EPS for the quarter, missing the consensus estimate of ($0.23) by ($0.09). Viewray had a negative return on equity of 62.98% and a negative net margin of 128.13%. The firm had revenue of $30.17 million during the quarter, compared to the consensus estimate of $25.92 million. During the same quarter last year, the company posted ($0.30) EPS. Viewray’s revenue for the quarter was up 83.5% on a year-over-year basis. As a group, research analysts forecast that Viewray Inc will post -1.18 EPS for the current fiscal year.

VRAY has been the topic of several research reports. TheStreet lowered Viewray from a “c-” rating to a “d” rating in a report on Friday, May 3rd. BidaskClub raised Viewray from a “strong sell” rating to a “sell” rating in a report on Thursday. Piper Jaffray Companies assumed coverage on shares of Viewray in a research report on Tuesday, June 18th. They issued an “overweight” rating and a $15.00 price objective for the company. Zacks Investment Research downgraded shares of Viewray from a “hold” rating to a “sell” rating in a research report on Friday, August 9th. Finally, Cantor Fitzgerald set a $13.00 price target on shares of Viewray and gave the company a “buy” rating in a research report on Tuesday, May 28th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and eight have given a buy rating to the company’s stock. Viewray has an average rating of “Buy” and a consensus target price of $11.75.

Hedge funds and other institutional investors have recently bought and sold shares of the business. Marshall Wace LLP grew its position in Viewray by 47.1% in the 1st quarter. Marshall Wace LLP now owns 131,179 shares of the company’s stock worth $970,000 after purchasing an additional 42,015 shares during the last quarter. Candriam Luxembourg S.C.A. grew its position in Viewray by 1,204.8% in the 1st quarter. Candriam Luxembourg S.C.A. now owns 132,857 shares of the company’s stock worth $982,000 after purchasing an additional 122,675 shares during the last quarter. Northern Trust Corp lifted its stake in shares of Viewray by 2.7% in the 4th quarter. Northern Trust Corp now owns 836,280 shares of the company’s stock worth $5,077,000 after acquiring an additional 22,187 shares during the period. Penn Capital Management Co. Inc. lifted its stake in shares of Viewray by 6.0% in the 1st quarter. Penn Capital Management Co. Inc. now owns 554,892 shares of the company’s stock worth $4,101,000 after acquiring an additional 31,327 shares during the period. Finally, LVZ Advisors Inc. acquired a new stake in shares of Viewray in the 1st quarter worth approximately $246,000.

Viewray Company Profile

ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.

Featured Story: How Does the Quiet Period Work?

Insider Buying and Selling by Quarter for Viewray (NASDAQ:VRAY)

Receive News & Ratings for Viewray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viewray and related companies with MarketBeat.com's FREE daily email newsletter.